Investors & Media
Medical Affairs
Contact

Investors & Media

At Vera Therapeutics, our mission is to pursue truth in science to transform medicine in autoimmune diseases, starting with kidney disease.

Stock Information

Minimum 15 minutes delayed. Source: LSEG

View more

Corporate Presentation

Download

Latest Press Releases

Sep 15, 2026

Vera Therapeutics Announces TRUTAKNA™ (atacicept-vymj) Stabilized eGFR and Prevented Kidney Disease Progression Through Two Years in ORIGIN 3 Final Efficacy Analysis in IgA Nephropathy

Sep 4, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 1, 2026

Vera Therapeutics to Participate at Upcoming Investor Conferences

Events & Presentations

Sep 15, 2026 5:35 PM EDT

Morgan Stanley 24th Annual Global Healthcare Conference

Sep 10, 2026 8:00 AM EDT

Cantor Global Healthcare Conference 2026

Jul 7, 2026 4:30 AM EDT

Virtual Investor Event: TRUTAKNA Accelerated Approval

Contact

INVESTOR INQUIRIES

IR@veratx.com

MEDIA INQUIRIES

corporatecommunications@veratx.com

Leaving this site

The link will take you to a third-party site and is not owned or controlled by Vera. Vera makes no representation as to the accuracy of the information contained on third-party sites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.